Low Expression of Mig-6 Is Associated With Poor Survival Outcome in NSCLC and Inhibits Cell Apoptosis via ERK-mediated Upregulation of BCL-2

Oncology Reports - Greece
doi 10.3892/or.2014.3050
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

FAM198B Is Associated With Prolonged Survival and Inhibits Metastasis in Lung Adenocarcinoma via Blockage of ERK-Mediated MMP-1 Expression

Clinical Cancer Research
Cancer ResearchOncology
2017English

Low Expression of TFPI-2 Associated With Poor Survival Outcome in Patients With Breast Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2013English

High Glucose Inhibits Apoptosis Induced by Serum Deprivation in Vascular Smooth Muscle Cells via Upregulation of BCL-2 and BCL-Xl

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2005English

Hypoxia-Induced Apoptosis Is Blocked by Adrenomedullin via Upregulation of BCL-2 in Human Osteosarcoma Cells

Oncology Reports
MedicineCancer ResearchOncology
2015English

Se-Methylselenocysteine Sensitized TRAIL-mediated Apoptosis via Down-Regulation of BCL-2 Expression

International Journal of Oncology
Cancer ResearchOncology
2009English

PIG3 Promotes NSCLC Cell Mitotic Progression and Is Associated With Poor Prognosis of NSCLC Patients

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2017English

Six1 Overexpression in Ovarian Carcinoma Causes Resistance to TRAIL-Mediated Apoptosis and Is Associated With Poor Survival

Cancer Research
Cancer ResearchOncology
2007English

Upregulation of the EMT Marker Vimentin Is Associated With Poor Clinical Outcome in Acute Myeloid Leukemia

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2018English

BCL-2 Blocks Cisplatin-Induced Apoptosis and Predicts Poor Outcome Following Chemoradiation Treatment in Advanced Oropharyngeal Squamous Cell Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy